XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Restricted Stock Units
Common Stock
Restricted Stock Units
Additional Paid-in Capital
Restricted stock
Restricted stock
Common Stock
Restricted stock
Additional Paid-in Capital
Beginning balance (in shares) at Feb. 02, 2020   264,008                
Beginning balance at Feb. 02, 2020 $ 830,118 $ 26 $ 2,107,579 $ 5,449 $ (1,282,936)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock upon exercise of stock options (in shares)   4,313                
Issuance of common stock upon exercise of stock options 21,626 $ 1 21,625              
Stock-based compensation expense 120,150   120,150              
Vesting of restricted stock units (in shares)           5,455        
Vesting of restricted stock units 0         $ 1 $ (1)      
Tax withholding on vesting of equity awards (in shares)   (219)                
Tax withholding on vesting of restricted stock (2,841)   (2,841)              
Repurchases of common stock (in shares)   (7,136)                
Repurchases of common stock (90,143) $ (1) (90,142)              
Other comprehensive income (loss) $ 6,736     6,736            
Cancellation of restricted stock (in shares) (230)                  
Cancellation of restricted stock $ 0                  
Common stock issued under employee stock purchase plan (in shares)   1,585                
Common stock issued under employee stock purchase plan 16,021   16,021              
Net loss (155,561)       (155,561)          
Ending balance (in shares) at Aug. 02, 2020   267,776                
Ending balance at Aug. 02, 2020 746,106 $ 27 2,172,391 12,185 (1,438,497)          
Beginning balance (in shares) at May. 03, 2020   263,970                
Beginning balance at May. 03, 2020 756,858 $ 26 2,120,189 10,173 (1,373,530)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock upon exercise of stock options (in shares)   2,138                
Issuance of common stock upon exercise of stock options 12,238 $ 1 12,237              
Stock-based compensation expense 61,456   61,456              
Vesting of restricted stock units (in shares)           2,930        
Vesting of restricted stock units 0   (1)     $ 1        
Tax withholding on vesting of equity awards (in shares)                 (85)  
Tax withholding on vesting of restricted stock               $ (1,467)   $ (1,467)
Repurchases of common stock (in shares)   (1,177)                
Repurchases of common stock (20,024) $ (1) (20,023)              
Other comprehensive income (loss) 2,012     2,012            
Net loss (64,967)       (64,967)          
Ending balance (in shares) at Aug. 02, 2020   267,776                
Ending balance at Aug. 02, 2020 746,106 $ 27 2,172,391 12,185 (1,438,497)          
Beginning balance (in shares) at Jan. 31, 2021   278,363                
Beginning balance at Jan. 31, 2021 750,006 $ 28 2,307,580 7,410 (1,565,012)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock upon exercise of stock options (in shares)   1,897                
Issuance of common stock upon exercise of stock options 11,284 $ 0 11,284              
Stock-based compensation expense 132,785   132,785              
Vesting of restricted stock units (in shares)           6,327        
Vesting of restricted stock units 0         $ 0 $ 0      
Tax withholding on vesting of equity awards (in shares)   (305)                
Tax withholding on vesting of restricted stock (6,564)   (6,564)              
Forfeiture of restricted stock (in shares)   (37)                
Forfeiture of restricted stock 0                  
Repurchases of common stock (in shares)   (3,696)                
Repurchases of common stock (74,393) $ 0 (74,393)              
Other comprehensive income (loss) (3,929)     (3,929)            
Common stock issued under employee stock purchase plan (in shares)   2,185                
Common stock issued under employee stock purchase plan 17,726   17,726              
Net loss (129,471)       (129,471)          
Ending balance (in shares) at Aug. 01, 2021   284,734                
Ending balance at Aug. 01, 2021 697,444 $ 28 2,388,418 3,481 (1,694,483)          
Beginning balance (in shares) at May. 02, 2021   283,352                
Beginning balance at May. 02, 2021 715,473 $ 28 2,359,895 4,768 (1,649,218)          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock upon exercise of stock options (in shares)   566                
Issuance of common stock upon exercise of stock options 3,389 $ 0 3,389              
Stock-based compensation expense 71,021   71,021              
Vesting of restricted stock units (in shares)           3,246        
Vesting of restricted stock units 0         $ 0        
Tax withholding on vesting of equity awards (in shares)   (80)                
Tax withholding on vesting of restricted stock (1,514)   (1,514)              
Forfeiture of restricted stock (in shares)                 (37)  
Forfeiture of restricted stock 0                  
Repurchases of common stock (in shares)   (2,313)                
Repurchases of common stock (44,373) $ 0 (44,373)              
Other comprehensive income (loss) (1,287)     (1,287)            
Net loss (45,265)       (45,265)          
Ending balance (in shares) at Aug. 01, 2021   284,734                
Ending balance at Aug. 01, 2021 $ 697,444 $ 28 $ 2,388,418 $ 3,481 $ (1,694,483)